Upper-body strength gains from different modes of resistance training in women who are underweight and women who are obese.

The purpose of this study was to determine the degree of upper-body strength gained by college women who are underweight and those who are obese using different modes of resistance training. Women who were underweight (UWW, n = 93, weight = 49.3 ± 4.5 kg) and women who were obese (OBW, n = 73, weight = 94.0 ± 15.1 kg) were selected from a larger cohort based on body mass index (UWW ≤ 18.5 kg·m⁻²; OBW ≥ 30 kg·m⁻²). Subjects elected to train with either free weights (FW, n = 38), supine vertical bench press machine (n = 52) or seated horizontal bench press machine (n = 76) using similar linear periodization resistance training programs 3× per week for 12 weeks. Each participant was assessed for upper-body strength using FWs (general) and machine weight (specific) 1 repetition maximum bench press before and after training. Increases in general and mode-specific strength were significantly greater for OBW (5.2 ± 5.1 and 9.6 ± 5.1 kg, respectively) than for UWW (3.5 ± 4.1 and 7.2 ± 5.2 kg, respectively). General strength gains were not significantly different among the training modes. Mode-specific gains were significantly greater (p < 0.05) than general strength gains for all groups. In conclusion, various resistance training modes may produce comparable increases in general strength but will register greater gains if measured using the specific mode employed for training, regardless of the weight category of the individual.

Acute hormonal response to sublingual androstenediol intake in young men.

The effectiveness of orally ingested androstenediol in raising serum testosterone concentrations may be limited because of hepatic breakdown of the ingested androgens. Because androstenediol administered sublingually with cyclodextrin bypasses first-pass hepatic catabolism, we evaluated the acute hormonal response to sublingual cyclodextrin androstenediol supplement in young men. Eight men (22.9 +/- 1.2 yr) experienced in strength training consumed either 20 mg androstenediol in a sublingual cyclodextrin tablet (Sl Diol) or placebo (Pl) separated by at least 1 wk in a randomized, double-blind, crossover manner. Blood samples were collected before supplementation and at 30-min intervals for 3 h after supplementation. Serum hormone concentrations did not change with Pl. Serum androstenedione concentrations were increased (P < 0.05) above baseline (11.2 +/- 1.1 nmol/l) with Sl Diol from 60 to 180 min after intake and reached a peak concentration of 25.2 +/- 2.9 nmol/l at 120 min. Serum free testosterone concentrations were increased from 86.2 +/- 9.1 pmol/l with Sl Diol from 30 to 180 min and reached a peak concentration of 175.4 +/- 12.2 pmol/l at 60 min. Serum total testosterone concentrations increased above basal (25.6 +/- 2.3 nmol/l) from 30 to 180 min with Sl Diol and reached a peak concentration of 47.9 + 2.9 nmol/l at 60 min. Serum estradiol concentrations were elevated (P < 0.05) above baseline (0.08 +/- 0.01 nmol/l) from 30 to 180 min with Sl Diol and reached 0.14 +/- 0.02 nmol/l at 180 min. These data indicate that sublingual cyclodextrin androstenediol intake increases serum androstenedione, free testosterone, total testosterone, and estradiol concentrations.